Cannabidiol (CBD), a non-intoxicating compound from the cannabis plant, is gaining traction as a daily wellness supplement. Unlike THC, CBD does not produce a high, making it an appealing option for those seeking natural relief from stress, pain, and sleep issues. Available in forms such as oils, capsules, gummies, and topicals, CBD offers flexibility for
READ MORE
Texas has taken a major step forward in medical marijuana policy. On June 25, Governor Greg Abbott signed a law expanding the state’s limited medical marijuana program, allowing up to 15 licensed companies—up from just three—to produce and sell more potent medical cannabis to a broader range of patients starting September 1. This expansion is
READ MORE
A chemical found in cannabis products, cannabinol, may soon be reclassified from a Class A to a Class B substance under Jersey’s Misuse of Drugs Law. Health and Care Minister Deputy Tom Binet revealed that the Misuse of Drugs Advisory Council recommended the change, responding to renewed calls for cannabis decriminalization. Cannabinol, commonly present in
READ MORE
The Trump administration’s 2026 budget proposal has ignited controversy by seeking to remove a key federal safeguard that has protected state-regulated medical cannabis programs from federal prosecution for over a decade. Since 2014, Congress has included language in its budget preventing the Department of Justice from targeting patients, caregivers, and providers who comply with state
READ MORE
CBD gummies are quickly becoming a mainstay in personal wellness routines, thanks to their convenience, consistency, and appeal. Unlike traditional self-care methods, which often relied on journaling or aromatherapy, today’s consumers are seeking practical products with tangible daily benefits. CBD, a compound found in cannabis that doesn’t produce a high, is now widely available in
READ MORE
Texas lawmakers are on the verge of significantly expanding the state’s medical marijuana program, even as a sweeping ban on hemp-derived THC products is poised to take effect. House Bill 46, which has passed both legislative chambers and now awaits final approval, would allow patients with chronic pain, Crohn’s disease, terminal illness, and those in
READ MORE
